Correction
After the publication of this work [1], we noticed that we had incorrectly used the term ‘OGX-011’. All instances of OGX-011 in the manuscript should be changed to ‘ASO-CLU’.
We apologise to the readers and OncoGenex Technologies for this oversight and any negative effects that may have resulted from it.
References
Chen : Clusterin confers gmcitabine resistance in pancreatic cancer. World J Surg Oncol. 2011, 9: 59-10.1186/1477-7819-9-59.
Author information
Authors and Affiliations
Corresponding author
Additional information
The online version of the original article can be found at 10.1186/1477-7819-9-59
Qingfeng Chen, Zhengkun Wang, Kejun Zhang contributed equally to this work.
Rights and permissions
Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution License ( https://creativecommons.org/licenses/by/2.0 ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
About this article
Cite this article
Chen, Q., Wang, Z., Zhang, K. et al. Erratum to: Clusterin confers gemcitabine resistance in pancreatic cancer. World J Surg Onc 11, 149 (2013). https://doi.org/10.1186/1477-7819-11-149
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/1477-7819-11-149